Media Center
Press Releases

Press Releases

06 Sep 17
Global dermatology pipeline to see shift towards increased usage of biologics, says GBI Research

The global dermatology pipeline, which currently comprises 850 products with a disclosed stage of development, is primarily made up of drugs at an early stage of development, with the late stages of the pipeline dominated by generics and biosimilars, according to business intelligence provider GBI Research.

Read post
06 Sep 17
Global Ophthalmology Market to surpass $35 billion by 2023, says GBI Research

The global ophthalmology market revenue is forecast to increase from $22.2 billion in 2016 to $35 billion in 2023, despite patents expiring for the therapy area’s three most successful products Avastin, Lucentis and Eylea, according to business intelligence provider GBI Research.

Read post
04 Sep 17
Cardiovascular Disease - Innovation within dyslipidemia, heart failure and thrombosis set to reduce high CVD mortality rate, says GBI Research

With over 1,400 products in active development, the innovation pipeline for cardiovascular disease (CVD) is extensive, with four key CVD indications – hypertension, heart failure, dyslipidemia and thrombosis – now accounting for around half of all pipeline innovation, according to GBI Research, a recognised leader in providing business information and analytics.

Read post
04 Sep 17
Hematological disorders to benefit from significant level of first-in-class innovation, says GBI Research

The hematological disorders therapy area, which covers indications such as sickle cell disease, paroxysmal nocturnal hemoglobinuria, anemia, thalassemia and hereditary hemochromatosis, is experiencing a significant level of first-in-class innovation, with 92 of its 327 pipeline programs with a disclosed molecular target identified as first-in-class, according to business intelligence provider GBI Research.

Read post
04 Sep 17
Asia-Pacific hepatitis C market to surpass $8.3 billion by 2023, says GBI Research

The hepatitis C market across the Asia-Pacific (APAC) region, which includes India, China, Australia, South Korea and Japan, is forecast to grow from $5.3 billion in 2016 to $8.3 billion by 2023, at a compound annual growth rate of 6.4%, according to business intelligence provider GBI Research.

Read post